Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia

[1]  N. Høiby,et al.  Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis , 2014, Respiratory Research.

[2]  J. Nick,et al.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. , 2014, Annals of the American Thoracic Society.

[3]  J. Leung,et al.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis , 2013, Current opinion in pulmonary medicine.

[4]  J. Adjemian,et al.  Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. , 2013, American journal of respiratory and critical care medicine.

[5]  J. Parkhill,et al.  Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study , 2013, The Lancet.

[6]  A. Lindblad,et al.  Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study , 2011, Diabetologia.

[7]  D. Rubinsztein,et al.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. , 2011, The Journal of clinical investigation.

[8]  S. Hoberman,et al.  Detection of Rapidly Growing Mycobacteria in Routine Cultures of Samples from Patients with Cystic Fibrosis , 2011, Journal of Clinical Microbiology.

[9]  P. Gilligan,et al.  Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  S. Holland,et al.  Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. , 2009, Respiratory medicine.

[11]  E. Tortoli,et al.  Characterization of Mycobacteria from a Major Brazilian Outbreak Suggests that Revision of the Taxonomic Status of Members of the Mycobacterium chelonae-M. abscessus Group Is Needed , 2009, Journal of Clinical Microbiology.

[12]  N. Høiby,et al.  Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[13]  E. Picard,et al.  Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel , 2008, Emerging infectious diseases.

[14]  D. Griffith.  Therapy of nontuberculous mycobacterial disease , 2007, Current opinion in infectious diseases.

[15]  C. Welinder-Olsson,et al.  Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis , 2007, Journal of Clinical Microbiology.

[16]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[17]  J. Emile,et al.  Hypervirulence of a Rough Variant of the Mycobacterium abscessus Type Strain , 2006, Infection and Immunity.

[18]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[19]  P. Molina,et al.  Nontuberculous mycobacterial infection in young children with cystic fibrosis , 2005, Pediatric pulmonology.

[20]  C. Piersimoni,et al.  Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. , 2002, Diagnostic microbiology and infectious disease.

[21]  H. Soini,et al.  Evaluation of GenoType and LiPA MYCOBACTERIA Assays for Identification of Finnish Mycobacterial Isolates , 2002, Journal of Clinical Microbiology.

[22]  C. Daley,et al.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria. , 2002, Clinics in chest medicine.

[23]  A. Lindgren,et al.  Demographic transition of the Swedish cystic fibrosis community--results of modern care. , 2002, Respiratory medicine.

[24]  J. Heesemann,et al.  Evaluation of BACTEC MGIT 960 and BACTEC 460TB Systems for Recovery of Mycobacteria from Clinical Specimens of a University Hospital with Low Incidence of Tuberculosis , 2001, Journal of Clinical Microbiology.

[25]  E. Tortoli,et al.  Identification of 54 Mycobacterial Species by PCR-Restriction Fragment Length Polymorphism Analysis of the hsp65Gene , 2001, Journal of Clinical Microbiology.

[26]  David Wypij,et al.  Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.

[27]  B. Petrini,et al.  Prospective study of mycobacterial infections in patients with cystic fibrosis. , 1990, Thorax.

[28]  J. Gaillard,et al.  Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[29]  B. Strandvik,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. , 2000, The European respiratory journal.

[30]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[31]  Peter R. Monge,et al.  Emergence of Communication Networks , 1999 .

[32]  N. Højlyng,et al.  The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. , 1994, Scandinavian journal of infectious diseases.

[33]  J. Kalbfleisch,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis. , 1984, The Journal of allergy and clinical immunology.